J&J hires Neil Patrick Harris to narrate Listerine "documentary"

Share this article:
J&J hires Neil Patrick Harris to narrate Listerine "documentary"
J&J hires Neil Patrick Harris to narrate Listerine "documentary"
Johnson & Johnson's McNeil division recruited actor Neil Patrick Harris (of Doogie Howser and Dr. Horrible fame) to narrate a three-minute online documentary on the history and uses of Listerine.

An outshoot of the brand's “Deepest Clean” TV campaign, it's a genre-bender -- part informational video, part gross-out and part horror movie. In a “Behind the scenes” clip at the campaign's website, thisisyourmouth.com, Harris snarks that after learning all about how overrun with bacteria our mouths are, he'll swish “two, maybe seven times a day.” The film also hints that not using mouthwash could lead to heart disease or diabetes.

“Emerging science suggests that advanced gum disease may be linked to other disorders, such as pneumonia, diabetes and heart disease,” says dentist John E. Dodes, DDS in the film, adding “Some studies have found oral bacteria in the arteries of people with heart disease.” At the end of the video, a disclaimer flashes on the screen, advising: “Emerging science suggests an association between periodontitis (advanced gum disease) and broader health problems, but a cause and effect relationship has not been established. Listerine Antiseptic has been indicated to help prevent or reduce plaque and gingivitis. It is not indicated for periodontitis or other diseases.”

For every viewing of the film, McNeil will donate a dollar to the Children's Oral Health Foundation (“America's Toothfairy”) up to $15,000. Edelman is handling PR for the film.
Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.